Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 6, 2021British journal of surgeryOpen Access

Management of the axilla after neoadjuvant chemotherapy in breast cancer patients

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMichael R. BolandZAZahraa Al‐Hilli

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Boland et al. (2021) studied this question.

synapsesocial.com/papers/6a83db46d65172829ee665cahttps://doi.org/10.1093/bjs/znab137
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: The SN FNAC Study2014 · 862 citations
  2. 2Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection2016 · 873 citations
  3. 3Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer2005 · 402 citations
  4. 4Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer2013 · 1,599 citations
  5. 5Value of a 21-gene expression assay on core biopsy to predict neoadjuvant chemotherapy response in breast cancer: systematic review and meta-analysis2021 · 40 citations